Flexion Therapeutics to Present at the 42nd Annual Raymond James Virtual Institutional Investors Conference
Flexion Therapeutics (Nasdaq:FLXN) announced that Dr. Michael Clayman, President and CEO, will participate in an analyst-led fireside chat at the 42nd Annual Raymond James Institutional Investors Conference. The virtual event is set for 12:30 p.m. ET on March 1, 2021. Interested parties can access the live webcast through the Flexion Therapeutics website, which focuses on innovative local therapies for musculoskeletal conditions, particularly osteoarthritis. Key company values include focus, ingenuity, tenacity, transparency, and fun.
- None.
- None.
BURLINGTON, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the 42nd Annual Raymond James Institutional Investors Conference. The virtual fireside chat is scheduled to begin at 12:30 p.m. ET on Monday, March 1, 2021.
To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.
Contact:
Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com
FAQ
When is Flexion Therapeutics' fireside chat at the Raymond James Institutional Investors Conference?
Who will represent Flexion Therapeutics at the conference?
How can I access the Flexion Therapeutics conference webcast?
What is the focus of Flexion Therapeutics?